{reportSlug=global-sicca-syndrome-drug-market, reportId=15079, mktKeyword=Sicca Syndrome Drug, cagr=0.00, publishDate=Nov 2021, priceOption2=7500, reportTitle=Sicca Syndrome Drug Comprehensive Study by Type (BMS-986142, Belimumab, Coversin, Filgotinib, LY-3090106, Others), Application (Hospital, Clinic, Others), Sales Channels (Online Sales Channel {Company Website, E-Commerce Platform}, Offline Sales Channels {Company store outlet, Hypermarket, and medical Stores}), Mode of Administration (Oral, Intravenous Route, Intramuscular Route, Subcutaneous Route, Rectal Route, Vaginal Route, Inhaled Route), Dosage Form (Effavescent tablet, Chewable tablet, Sublingual tablet, Enteric coated tablet, Capsule, Powder, Lozenges, Mixtures, Implant, Irrigation solution, Lotion, Gargle, Ointment, Drops, Cream, Injections, Suppository, Transdermal patch, Inhaler) Players and Region - Global Market Outlook to 2026, baseYr=2019, totalTableFig=215, priceOption1=3750, forecastYr=2027, noOfPages=206, reportKey=15009, breadcrum=Global Sicca Syndrome Drug}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Nov 2021 206 Pages 57 Tables Base Year: 2019 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales